4.46 USD
▼-0.12-2.62%
盘后 4.50 +0.90%
2026-09-15
市值
$887.70M
市盈率
—
EPS
-1.08
股息率
—
52 周区间
4.40 – 21.73
成交量
2.29M
Beta
-1.30
目标价
18.53
52W 低 4.4052W 高 21.73
价格走势
公司简介
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscula...